ATE273995T1 - Spezifische inhibitoren der pankreatischen lipase und deren anwendungen - Google Patents
Spezifische inhibitoren der pankreatischen lipase und deren anwendungenInfo
- Publication number
- ATE273995T1 ATE273995T1 AT98902026T AT98902026T ATE273995T1 AT E273995 T1 ATE273995 T1 AT E273995T1 AT 98902026 T AT98902026 T AT 98902026T AT 98902026 T AT98902026 T AT 98902026T AT E273995 T1 ATE273995 T1 AT E273995T1
- Authority
- AT
- Austria
- Prior art keywords
- pancreatic lipase
- applications
- lipase inhibitors
- specific pancreatic
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9700071A FR2758143B1 (fr) | 1997-01-07 | 1997-01-07 | Inhibiteurs specifiques de la lipase pancreatique et leurs applications |
PCT/FR1998/000009 WO1998030588A1 (fr) | 1997-01-07 | 1998-01-06 | Inhibiteurs specifiques de la lipase pancreatique et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE273995T1 true ATE273995T1 (de) | 2004-09-15 |
Family
ID=9502405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98902026T ATE273995T1 (de) | 1997-01-07 | 1998-01-06 | Spezifische inhibitoren der pankreatischen lipase und deren anwendungen |
Country Status (14)
Country | Link |
---|---|
US (1) | US6432400B1 (de) |
EP (1) | EP0970118B1 (de) |
CN (1) | CN1248264A (de) |
AT (1) | ATE273995T1 (de) |
AU (1) | AU727469B2 (de) |
BR (1) | BR9806857A (de) |
CA (1) | CA2277778C (de) |
CZ (1) | CZ294206B6 (de) |
DE (1) | DE69825733T2 (de) |
FR (1) | FR2758143B1 (de) |
HU (1) | HUP0001458A3 (de) |
NZ (1) | NZ337087A (de) |
WO (1) | WO1998030588A1 (de) |
ZA (1) | ZA9894B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000226335A (ja) * | 1998-12-04 | 2000-08-15 | Amano Pharmaceut Co Ltd | 経口用酵素製剤、酵素含有食材及び酵素製剤の服用方法 |
US6697668B2 (en) | 2001-01-25 | 2004-02-24 | Iomed, Inc. | Ocular iontophoretic device and method for using the same |
FR2824334B1 (fr) | 2001-05-03 | 2003-10-10 | Coletica | Procede pour tester une substance eventuellement active dans le domaine de la lipolyse et son utilisation principalement cosmetique |
US20040018197A1 (en) * | 2002-04-26 | 2004-01-29 | Promega Corporation | Treatment for weight loss |
US20040077530A1 (en) * | 2002-10-18 | 2004-04-22 | Robert Portman | Composition for reducing caloric intake |
EP1616194A2 (de) * | 2003-04-08 | 2006-01-18 | Genova, Ltd. | Sektretierte polypeptidspezies assoziiert mit herzgefässerkrankungen |
SE0302253D0 (sv) | 2003-08-21 | 2003-08-21 | Forskarpatent I Syd Ab | Lipase-colipase inhibitor |
GB0920633D0 (en) | 2009-11-25 | 2010-01-13 | Rdbiomed Ltd | Inhibition of pancreatic lipase |
FR2966734B1 (fr) | 2010-10-29 | 2014-07-18 | Max Rombi | Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides |
US20130144540A1 (en) * | 2011-12-06 | 2013-06-06 | Palo Alto Research Center Incorporated | Constrained de novo sequencing of peptides |
WO2017079299A1 (en) * | 2015-11-03 | 2017-05-11 | Mayo Foundation For Medical Education And Research | Using colipase inhibitors to treat pancreatitis |
JP7224331B2 (ja) | 2017-07-12 | 2023-02-17 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | 脂肪毒性損傷の低減のための化合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5248598A (en) * | 1989-05-25 | 1993-09-28 | Ivan E. Modrovich | Lipase single reagent system |
-
1997
- 1997-01-07 FR FR9700071A patent/FR2758143B1/fr not_active Expired - Fee Related
-
1998
- 1998-01-06 WO PCT/FR1998/000009 patent/WO1998030588A1/fr active IP Right Grant
- 1998-01-06 BR BR9806857-1A patent/BR9806857A/pt not_active IP Right Cessation
- 1998-01-06 HU HU0001458A patent/HUP0001458A3/hu unknown
- 1998-01-06 EP EP98902026A patent/EP0970118B1/de not_active Expired - Lifetime
- 1998-01-06 CZ CZ19992414A patent/CZ294206B6/cs not_active IP Right Cessation
- 1998-01-06 NZ NZ337087A patent/NZ337087A/xx unknown
- 1998-01-06 CN CN98801703A patent/CN1248264A/zh active Pending
- 1998-01-06 AT AT98902026T patent/ATE273995T1/de not_active IP Right Cessation
- 1998-01-06 DE DE69825733T patent/DE69825733T2/de not_active Expired - Lifetime
- 1998-01-06 AU AU58686/98A patent/AU727469B2/en not_active Ceased
- 1998-01-06 US US09/341,184 patent/US6432400B1/en not_active Expired - Lifetime
- 1998-01-06 CA CA2277778A patent/CA2277778C/fr not_active Expired - Lifetime
- 1998-01-07 ZA ZA9894A patent/ZA9894B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2758143A1 (fr) | 1998-07-10 |
ZA9894B (en) | 1998-07-08 |
US6432400B1 (en) | 2002-08-13 |
HUP0001458A2 (hu) | 2000-10-28 |
CN1248264A (zh) | 2000-03-22 |
CZ241499A3 (cs) | 2000-01-12 |
WO1998030588A1 (fr) | 1998-07-16 |
BR9806857A (pt) | 2000-03-14 |
AU727469B2 (en) | 2000-12-14 |
DE69825733D1 (de) | 2004-09-23 |
DE69825733T2 (de) | 2005-09-01 |
FR2758143B1 (fr) | 1999-02-19 |
EP0970118A1 (de) | 2000-01-12 |
EP0970118B1 (de) | 2004-08-18 |
CA2277778C (fr) | 2013-07-02 |
CA2277778A1 (fr) | 1998-07-16 |
AU5868698A (en) | 1998-08-03 |
CZ294206B6 (cs) | 2004-10-13 |
NZ337087A (en) | 2001-01-26 |
HUP0001458A3 (en) | 2001-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1019040E (pt) | Inibicao da actividade de p38-quinase por meio de arilureias | |
DE69825733D1 (de) | Spezifische inhibitoren der pankreatischen lipase und deren anwendungen | |
MXPA05003493A (es) | Metodos para generar y seleccionar proteasas con especificidad alterada. | |
DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
HUP0500560A2 (hu) | Mikróbás enzimek új keverékei | |
WO2004047760A3 (en) | Novel chemical compounds | |
ATE415423T1 (de) | Immunisierungstherapie zur behandlung von atherosklerose | |
ATE419858T1 (de) | Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen | |
TR200500221T2 (tr) | Farmasötik Maddeler Olarak Bisiklik Amino Asitler | |
DK1043982T3 (da) | Lipasehammende polymerer | |
BR0011838B1 (pt) | elemento de sela e estrutura de misturador estático. | |
ZA99133B (en) | Transgenic rabbit that expresses a functional human lipoprotein (A). | |
ES2081857T3 (es) | Nuevos inhibidores de alpha-glucosidasa. | |
ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
TW200504078A (en) | Therapeutically active compounds and their use | |
ATE292801T1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
ATE429927T1 (de) | Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten | |
ATE226254T1 (de) | Reagenz zur behandlung von arthritischen zustaenden | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
PT996709E (pt) | Inibidores de enzimas celuloliticas, xilanoliticas e betaglucanoliticas | |
ATE338566T1 (de) | Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten | |
ATE246924T1 (de) | Neue therapeutische verwendung von nicergoline | |
ATE213644T1 (de) | Kombinationstherapie für die behandlung von arthritis erkrankungen | |
ATE275949T1 (de) | Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria | |
DE59902857D1 (de) | Mittel zur spezifischen hemmung osteoklastärer knochenresorption |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |